deferoxamine has been researched along with thiophenes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bobrovová, Z; Haskova, P; Holeckova, M; Hrdina, R; Jansson, PJ; Kalinowski, DS; Mazurová, Y; Mladĕnka, P; Nachtigal, P; Palicka, V; Richardson, DR; Semecký, V; Simůnek, T; Vávrová, J | 1 |
1 other study(ies) available for deferoxamine and thiophenes
Article | Year |
---|---|
The novel iron chelator, 2-pyridylcarboxaldehyde 2-thiophenecarboxyl hydrazone, reduces catecholamine-mediated myocardial toxicity.
Topics: Animals; Catecholamines; Cell Line; Deferoxamine; Iron; Iron Chelating Agents; Isoproterenol; Male; Myocytes, Cardiac; Oxidation-Reduction; Rats; Rats, Wistar; Thiophenes | 2009 |